RxDoctor Payments DataLook up a doctor →

Chrystal Means, PA

Physician Assistant · Frankfort, KYNPI 1497710180

Payments from drug & device makers

$7,959in general payments, 2019–2025

Across 491 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • AstraZeneca$889
  • Lilly USA, LLC$864
  • Pfizer$627
  • GSK$375
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$7,91899%
  • Education$411%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,959 in reported general payments places this provider in the 95th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$40,479
Medicare patients
152
Services billed
935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin73$84,598
Trelegy ElliptaFluticasone/Umeclidin/Vilanter84$71,908
JanuviaSitagliptin Phosphate33$34,958
MounjaroTirzepatide25$31,976
Janumet XrSitagliptin Phos/Metformin Hcl23$29,663
EliquisApixaban27$23,190
OzempicSemaglutide20$22,646
LinzessLinaclotide17$17,393
VraylarCariprazine Hcl12$17,058
FarxigaDapagliflozin Propanediol15$14,209
BrilintaTicagrelor17$7,644
Breo ElliptaFluticasone/Vilanterol13$6,655
Jentadueto XrLinagliptin/Metformin Hcl13$6,607
Albuterol Sulfate HfaAlbuterol Sulfate153$3,708
Levothyroxine Sodium263$3,488

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Jentadueto Xr$249$91,20586 claims
GSKTrelegy Ellipta, Breo Ellipta$375$78,56497 claims
MerckJanuvia, Janumet Xr$27$64,62156 claims
AbbVieLinzess, Vraylar$1,116$34,45229 claims
Lilly USA, LLCMounjaro$864$31,97625 claims
PfizerEliquis$627$23,19027 claims
Novo NordiskOzempic$1,139$22,64620 claims
AstraZenecaFarxiga, Brilinta$889$21,85432 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$136$2,97911 claims
Almatica Pharma LLCSertraline Hcl$21$1,169140 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Frankfort

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →